Representative before the EPO

Employment test 1 - 10 employees
Company dna huber and schussler
operating since 1996
Headquarter in Munich and 1 office
active in Legal Services and IP Consulting

Andrea Schüssler has worked on the following 145 EPO patent applications which have been published in the last five years:

EP11721695

PURIFICATION DEVICE AND METHOD FOR ADVANCEDLY TREATING PRINTING AND DYEING WASTEWATER

IPC classification:
C02F 1/44, C02F 1/461, C02F 1/66, C02F 9/06, C02F 103/30
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP11737889

REARRANGED TT VIRUS MOLECULES FOR USE IN DIAGNOSIS, PREVENTION AND TREATMENT OF CANCER AND AUTOIMMUNITY

IPC classification:
C07K 14/01, C12Q 1/70
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP10803562

ANTIBODY THAT BINDS TO H-1 PARVOVIRUS

IPC classification:
C07K 16/08, G01N 33/569
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11727100

APPARATUS AND METHOD FOR PURIFYING AND STERILIZING WATER USING NANO CATALYTIC MICROELECTROLYSIS

IPC classification:
C02F 1/00, C02F 1/44, C02F 1/461, C02F 1/467, C02F 1/50, C02F 1/66, C02F 9/06, C02F 101/10, C02F 101/20, C02F 101/30, C02F 103/08
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP11784588

ROD SHAPED BODY AND MEDICAL DEVICE

IPC classification:
A61L 27/50, A61L 29/14, A61L 29/18, A61L 31/18
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP12004121

3-((N-ACYLATED AMINOACYL)AMINO)PYRAZOLES AS INHIBITORS OF BETA-AMYLOID PEPTIDE PRODUCTION USEFUL FOR THE TREATMENT OF ALZHEIMER'S DISEASE

IPC classification:
A61K 31/415, A61P 25/28, C07D 231/40, C07D 401/04, C07D 401/06, C07D 401/12, C07D 405/04, C07D 405/12, C07D 409/12
Applicant:
Elan Pharmaceuticals Inc.
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12007415

Viral particles derived from an enveloped virus

IPC classification:
A61K 39/21
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP12723823

IMPLANTABLE OR INSERTABLE MRI-DETECTABLE MEDICAL DEVICE HAVING A COATING COMPRISING PARAMAGNETIC IONS AND A PROCESS FOR PREPARING IT

IPC classification:
A61L 27/34, A61L 29/08, A61L 29/18, A61L 31/10, A61L 31/14
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP12749698

FRICTION REDUCTION FOR ENGINE COMPONENTS

IPC classification:
F02F 1/20
Applicant:
The George Washington University
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP11005568

Adeno-parvovirus chimera with enhanced oncolytical potential

IPC classification:
C12N 7/00, C12N 15/861, C12N 15/864
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11004884

Oncolytic virotherapy for therapy of bone cancer

IPC classification:
A61K 35/76, A61P 35/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11175266

Functionalization of RNA oligonucleotides

IPC classification:
C12Q 1/68
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11704934

METHOD AND SYSTEM FOR THE PRODUCTION OF CBM (COMPRESSED BIOMETHANE) AS A GREENHOUSE GAS-REDUCED FUEL

IPC classification:
C12P 5/02
Agent:
Andreas Lucke, Boehmert & Boehmert Anwaltspartnerschaft mbB
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP12777183

LUBRICATING OIL ADDITIVE COMPOSITION AND METHOD FOR IMPROVING STORAGE STABILITY OF LUBRICATING OIL ADDITIVE COMPOSITION

IPC classification:
C10M 135/26, C10N 20/00, C10N 30/06, C10N 30/10, C10N 40/00, C10N 40/02, C10N 40/04, C10N 40/08, C10N 40/12, C10N 40/20, C10N 40/25, C10N 40/30, C10N 50/10
Applicant:
Adeka Corporation
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP11007142

Multiple orthogonal labelling of oligonucleotides

IPC classification:
C07H 21/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12006666

New spiroepoxide tetrahydrobenzo-triazoles and -imidazoles and their use as MetAP-II inhibitors

IPC classification:
A61K 31/4188, A61K 31/4192, A61P 35/00, C07D 491/107
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11819862

LUBRICANT COMPOSITION FOR INTERNAL COMBUSTION ENGINES

IPC classification:
C10M 135/18, C10M 137/10, C10M 139/00, C10M 141/10, C10M 169/04, C10N 10/12, C10N 20/02, C10N 30/06, C10N 30/08, C10N 40/25
Applicant:
Adeka Corporation
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP11009625

HPV derived polynucleic acids for therapy

IPC classification:
A61K 39/00, A61K 39/12, C07K 14/025, C12N 15/62
Applicant:
King Saud University
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12827573

NEW REACTIVE SURFACTANTS FOR EMULSION POLYMERIZATION, PIGMENT DISPERSION, AND UV COATINGS

IPC classification:
C07C 43/11, C08G 65/02, C08G 65/22, C08G 65/26, C08G 65/28, C08G 65/334, C08G 65/40, C09D 171/00, C09D 171/02, C09D 171/10
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP12830004

SYSTEMS AND METHODS FOR ASSESSMENT OF BIOSIMILARITY

IPC classification:
C12N 5/10, C12N 15/63, C12Q 1/02
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP13003854

Method for producing finely pulverized organic compound particle

IPC classification:
A61K 9/00, A61K 9/14, A61K 31/015, A61K 31/192, A61K 31/216, A61K 31/404, A61K 31/41, A61K 31/4174, A61K 31/4422, A61K 31/4704, A61K 31/56, A61K 31/57
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12778038

MEDICAL DEVICE FOR INSERTION INTO THE HUMAN OR ANIMAL BODY

IPC classification:
A61B 17/00, A61N 1/05, A61N 1/08
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11766672

COMPOSITIONS AND METHODS FOR IDENTIFYING AUTISM SPECTRUM DISORDERS

IPC classification:
C12Q 1/68, C40B 30/04
Applicant:
The George Washington University
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13001478

Recombinant viral vectors

IPC classification:
A61K 39/21
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP13003408

Central vacuum cleaning system

IPC classification:
A47L 5/38, A47L 9/28
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13003261

HIV-1 env glycoprotein variant

IPC classification:
A61K 39/21, C07K 14/16, C12N 7/00
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP12840238

AN HIV-1 GP120 MINI V3 LOOP AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/21, A61K 39/395, A61K 39/42
Applicant:
The Scripps Research Institute
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP12842284

ANTI-GAP43 ANTIBODY

IPC classification:
C07K 16/18, C12N 5/10, C12N 15/09, C12P 21/08, G01N 33/53, G01N 33/543, G01N 33/577
Applicant:
Niigata University
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP12841847

NEW REACTIVE SURFACTANTS FOR FREEZE-THAW STABLE EMULSION POLYMERS AND COATINGS THEREOF

IPC classification:
C07C 43/11, C08G 65/02, C08G 65/22, C08G 65/28, C08G 65/334, C08G 65/38, C08G 65/40, C08L 71/00, C08L 71/02, C08L 71/10, C09D 171/00, C09D 171/02, C09D 171/10
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP12005669

Implantable or insertable MRI-detectable medical device having a coating comprising paramagnetic ions and a process for preparing it

IPC classification:
A61L 27/34, A61L 29/08, A61L 29/18, A61L 31/10, A61L 31/14
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP12839673

ENGINEERED OUTER DOMAIN (EOD) OF HV GP120 AND MUTANTS THEREOF

IPC classification:
A61K 38/00, A61K 39/21, G01N 33/564
Applicant:
The Scripps Research Institute
Applicant:
University of Washington CoMotion
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP11810195

BIFUNCTIONAL RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE

IPC classification:
A61K 51/00, A61M 36/14
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION WITHDRAWN
EP12847222

A DRUG SCREENING METHOD AND USES THEREOF

IPC classification:
H01L 27/146
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12796855

PHARMACEUTICAL COMPOSITIONS CONTAINING PEDIOCOCCUS AND METHODS FOR REDUCING THE SYMPTOMS OF GASTROENTEROLOGICAL SYNDROMES

IPC classification:
A23L 1/30, A61K 9/00, A61K 35/66, A61P 1/00, A61P 1/14
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP11751266

HIV-1 ENVELOPE BASED FRAGMENTS

IPC classification:
A61K 38/00, A61K 39/21, C07K 14/005, G01N 33/569, G01N 33/68
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12001433

Organ perfusion system

IPC classification:
A01N 1/02
Applicant:
Rodos BioTarget GmbH
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12858632

FRICTION AND WEAR REDUCING AGENT FOR LUBRICATING OIL AND LUBRICATING OIL COMPOSITION CONTAINING SAME

IPC classification:
C10M 145/14, C10M 169/04, C10N 20/04, C10N 30/06, C10N 40/00, C10N 40/02, C10N 40/04, C10N 40/08, C10N 40/12, C10N 40/16, C10N 40/20, C10N 40/25, C10N 40/30, C10N 50/10
Applicant:
Adeka Corporation
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP12006716

Mitochondrial expression vector and process for the transformation of mitochondria

IPC classification:
A61K 48/00
Applicant:
Universität Leipzig KöR
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12706453

STENT FOR SPLINTING A NASAL PASSAGE

IPC classification:
A61F 2/90, A61F 5/08, A61F 5/56
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP12735448

ONCOLYTIC VIROTHERAPY FOR THE THERAPY OF SARCOMA

IPC classification:
A61K 35/76, A61P 35/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13705388

MODIFIED PARVOVIRUS USEFUL FOR GENE SILENCING

IPC classification:
A01K 67/027, C12N 15/113, C12N 15/86, C12N 15/864
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP13751283

NATURAL OIL DERIVED GELLED INK VEHICLES

IPC classification:
C09D 11/06, C09D 191/00, C09F 7/00
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP13758198

WATER BORNE EPOXY RESIN DISPERSIONS AND EPOXY HARDENER COMPOSITIONS

IPC classification:
C08F 20/10, C08K 5/107, C08L 63/00
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP13761294

ADDITIVES TO IMPROVE OPEN-TIME AND FREEZE-THAW CHARACTERISTICS OF WATER-BASED PAINTS AND COATINGS

IPC classification:
C07C 15/24, C07C 43/11, C08G 65/02, C08G 65/22, C08G 65/28, C08G 65/38, C08G 65/40, C08L 71/00, C08L 71/02, C08L 71/10, C09D 171/00, C09D 171/02, C09D 171/10
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP12766277

MULTIPLE ORTHOGONAL LABELLING OF OLIGONUCLEOTIDES

IPC classification:
C07H 21/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14003384

Rod shaped body and medical device

IPC classification:
A61L 27/50, A61L 29/18, A61L 31/18
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP13003664

Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor

IPC classification:
A61K 31/495, A61K 31/5377, A61K 35/76, A61K 45/06
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12005565

Recombinant Adeno-Associated virus (AAV) vector particles displaying high-affinity ligands for cell-type specific gene delivery

IPC classification:
A61K 48/00, C07K 14/005, C12N 15/86
Applicant:
University of Cologne (Universität zu Köln)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13003810

Compositions for ameliorating and/or preventing adverse side effects in antibiotic therapy

IPC classification:
A61K 31/165, A61K 31/19, A61K 31/5375, A61K 31/65, A61K 31/7072, A61K 45/06, A61P 31/04
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13712479

ORGAN PERFUSION SYSTEM

IPC classification:
A01N 1/02
Applicant:
Rodos BioTarget GmbH
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP12732785

MODULATORS OF ADP-DEPENDENT GLUCOKINASE (ADPGK) AND GLYCEROL-3-PHOSPHATE DEHYDROGENASE (GPD2) FOR THERAPY

IPC classification:
A61P 35/00, A61P 37/00, C12N 9/04, C12N 9/12, C12N 15/113
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13778030

FUSED AROMATIC PHOSPHONATE DERIVATIVES AS PRECURSORS TO PTP-1B INHIBITORS

IPC classification:
A61K 31/662, A61K 31/665, A61P 3/00, A61P 35/00, C07F 9/40, C07F 9/6571
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13718786

INHIBITORS OF THIOREDOXIN-INTERACTING PROTEIN (TXNIP) FOR THERAPY

IPC classification:
C07K 14/47, C12N 15/113
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14003071

Tunable acoustic wave filter switchable between band pass and band reject characteristics

IPC classification:
H03H 9/54, H03H 9/64, H03H 9/70, H03H 9/72
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP14003072

Methods of identifying novel HIV-1 immunogens

IPC classification:
G01N 33/543, G01N 33/569
Applicant:
Laboratory Corporation of America Holdings
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13788498

METHOD FOR IMPROVING THE EFFECTIVENESS OF TITANIUM DIOXIDE CONTAINING COATINGS

IPC classification:
C08J 3/20, C08K 3/22, C09D 5/02, C09D 17/00
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP13853302

TECHNOLOGICAL PROCESS FOR FLEXIBLE SINTERING OF RARE EARTH PERMANENTLY MAGNETIC ALLOY AND APPARATUS THEREFOR

IPC classification:
B22F 3/10, H01F 1/057, H01F 1/08
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP13853877

VACUUM-INDUCED SMELTING AND RAPID HARDENING APPARATUS FOR RARE EARTH PERMANENT MAGNETIC ALLOY

IPC classification:
B22D 11/06, C22C 33/02, C22C 38/00, C22C 45/02, H01F 1/057
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP13797296

FLUORESCENT PROBE FOR HIGH-SENSITIVITY PANCREATIC FLUID DETECTION, AND METHOD FOR DETECTING PANCREATIC FLUID

IPC classification:
C07D 493/10, C09B 11/28, C09K 11/06, C12M 1/00, C12M 1/34, C12Q 1/37, C12Q 1/48, G01N 21/64, G01N 21/78
Applicant:
University of Tokyo
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP13800483

PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION AND PAIN

IPC classification:
A61K 31/095, A61K 31/10, A61P 25/00, A61P 29/00
Applicant:
Olatec Industries LLC
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP13800313

METHOD FOR TREATING SKIN INFLAMMATORY DISEASES

IPC classification:
A61K 9/06, A61K 9/08, A61K 31/095, A61K 31/10, A61P 17/00, A61P 29/00
Applicant:
Olatec Industries LLC
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP13800363

PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION AND PAIN

IPC classification:
A61K 9/06, A61K 9/70, A61K 31/095, A61K 31/10, A61P 25/00, A61P 29/00
Applicant:
Olatec Industries LLC
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP13804151

COMPOUNDS FOR TREATING INFLAMMATION AND PAIN

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/095, A61K 31/10, A61P 25/00, A61P 29/00
Applicant:
Olatec Industries LLC
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP13803656

STABLE PEXIGANAN FORMULATION

IPC classification:
A01N 25/22, A01N 25/30, A61P 31/02, A61P 31/04
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP13804724

COMPOUNDS FOR TREATING INFLAMMATION AND PAIN

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/095, A61K 31/26, A61P 29/00
Applicant:
Olatec Industries LLC
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP13004991

Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer

IPC classification:
A61K 51/04, A61P 35/00, C07B 59/00, C07D 295/145
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION WITHDRAWN
EP13807585

SYNTHESIS OF BETA-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS

IPC classification:
C07K 1/107, C07K 5/12
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP13005138

HCBI sequences as an early marker for the future development of cancer and diseases of the CNS and as a target for cancer treatment and prevention

IPC classification:
C12Q 1/68
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13756309

IMPLANTABLE OR INSERTABLE MRI-DETECTABLE MEDICAL DEVICE HAVING A COATING COMPRISING PARAMAGNETIC IONS AND A PROCESS FOR PREPARING IT

IPC classification:
A61L 27/34, A61L 29/08, A61L 29/18, A61L 31/10, A61L 31/14
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP13825808

AMORPHOUS CABAZITAXEL

IPC classification:
A61K 31/337, A61P 35/00, C07D 305/14
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12006568

Accessory for beverage container and method

IPC classification:
A47G 23/02
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13829904

STABLE PHARMACEUTICAL FORMULATION OF CABAZITAXEL

IPC classification:
A61K 9/08, A61K 31/164, A61K 31/56
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP12883581

NETWORKED OPERATION SCHEDULING SYSTEM FOR RAILWAY VEHICLES BASED ON ELECTRONIC INTERVALS

IPC classification:
B61L 23/00
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP11830116

METHODS AND COMPOSITIONS USING ANTI-LPS LIGANDS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISORDERS

IPC classification:
A61K 35/20, A61K 39/02, A61K 39/40, A61P 1/12, C07K 16/12
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13839430

PROBIOTIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF OBESITY AND OBESITY-RELATED CONDITIONS

IPC classification:
A61K 35/66, A61K 35/74, A61P 3/04, A61P 3/08, A61P 3/10, A61P 9/10, C12N 1/20, C12R 1/23, C12R 1/24, C12R 1/245, C12R 1/25, C12R 1/46, C12R 1/85
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP11833157

METHOD FOR TREATING CYSTIC FIBROSIS WITH INHALED DENUFOSOL

IPC classification:
A61K 31/7072, A61P 11/00
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11813019

METHOD FOR TREATING OPHTHALMIC DISEASES USING KINASE INHIBITOR COMPOUNDS IN PRODRUG FORMS

IPC classification:
A01N 43/34
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15001026

Acoustic wave filter with cutoff frequency stabilized against temperature drift

IPC classification:
H03H 9/54, H03H 9/64, H03H 9/70, H03H 9/72
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP15001028

TEMPERATURE AND PROCESS COMPENSATED TUNABLE ACOUSTIC WAVE FILTER

IPC classification:
H03H 9/54, H03H 9/64, H03H 9/70, H03H 9/72
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP15001027

TEMPERATURE AND PROCESS COMPENSATED TUNABLE ACOUSTIC WAVE FILTER

IPC classification:
H03H 9/54, H03H 9/64, H03H 9/70, H03H 9/72
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP15001025

BIOGAS SYSTEM AND METHOD FOR GENERATING BIOGAS FROM STRAW

IPC classification:
C12M 1/107
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP15000919

BIOGAS SYSTEM AND METHOD FOR GENERATING BIOGAS FROM STRAW

IPC classification:
C12M 1/107
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP14164523

Trifunctional antigen-binding molecule

IPC classification:
C07K 16/28, C07K 16/46
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11815916

SAFETY EQUIPMENT BAG

IPC classification:
A62B 25/00, B65D 30/00, B65D 33/34, B65D 65/28
Agent:
Peter John Bracey Gray, Thompson Gray LLP
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP14738145

GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS AS ANTI-CANCER AGENTS

IPC classification:
A61K 31/365, A61P 35/00, C07D 309/10, C07D 493/04
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP15000390

Methods and devices for powdering NdFeB rare earth permanent magnetic alloy

IPC classification:
B02C 19/06, B02C 23/12, B22F 9/04, C22C 1/04, H01F 1/057, H01F 41/02
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP11714685

Cancer therapy with a parvovirus combined with an HDAC inhibitor

IPC classification:
A61K 31/165, A61K 31/19, A61K 35/76, A61K 45/06, A61P 35/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14176624

HCBI, MSBI, MSSI and CMI sequences as an early marker for the future development of cancer and diseases of the CNS and as a target for the treatment and prevention of these diseases

IPC classification:
C12Q 1/68, C12Q 1/70
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15001720

BROADLY NEUTRALIZING ANTIBODY AND USES THEREOF

IPC classification:
C07K 16/10
Applicant:
Cornell University
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP15154772

CD3 binding domain

IPC classification:
C07K 16/28, C07K 16/30, C07K 16/46
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15171431

A MONOCLONAL ANTIBODY AND A METHOD THEREOF

IPC classification:
A61K 39/395, A61P 17/06, A61P 19/02, A61P 37/06, C07K 16/28
Applicant:
Biocon Limited
Agent:
Kate Laura Taylor, HGF Limited
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP12000554

Modified parvovirus useful for gene silencing

IPC classification:
A01K 67/027, C12N 15/113, C12N 15/864
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15002837

CATHETER DEVICE

IPC classification:
A61M 1/10, A61M 1/12
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP15002836

CATHETER DEVICE

IPC classification:
A61M 1/10, A61M 1/12
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP14736649

TTV MIRNA SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER AND AS A TARGET FOR CANCER TREATMENT AND PREVENTION

IPC classification:
C12N 15/113
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP14003570

18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents

IPC classification:
A61K 51/06
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14755588

COMPOSITIONS FOR AMELIORATING AND/OR PREVENTING ADVERSE SIDE EFFECTS IN ANTIBIOTIC THERAPY

IPC classification:
A61K 31/165, A61K 31/19, A61K 31/5375, A61K 31/65, A61K 31/7072, A61K 45/06
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP14758087

ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30, C07K 16/46
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP13001745

System for removal of organic contaminants from bio-gas for renewable energy production

IPC classification:
B01D 53/14, B01D 53/22, B01D 53/75, B01D 53/86, B01D 61/02, C10L 3/10, C12M 1/00
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14838001

PHARMACEUTICAL COMPOSITION AND USE OF DIETHYL (2-CYANOETHYL)PHOSPHONATE

IPC classification:
A61K 9/06, A61K 9/20, A61K 9/70, A61K 47/06
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP15003131

COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS

IPC classification:
A61K 9/00, A61K 9/70, A61K 31/352, A61K 36/82, A61K 38/36, A61K 38/40, A61K 38/43, A61K 38/47, A61K 38/48, A61P 19/00, A61P 27/16
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP12002914

Inhibitors of thioredoxin-interacting protein (TXNIP) for therapy

IPC classification:
C07K 14/47, C07K 16/18, C12N 15/113
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP14799340

LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER

IPC classification:
C07B 59/00, C07D 295/145
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION IN PROGRESS
EP14851100

PHARMACEUTICAL USE OF 3-BENZYLSULFONYLPROPIONITRILE

IPC classification:
C07C 317/32
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
GRANT OF PATENT INTENDED
EP15154629

Cancer therapy with a parvovirus combined with bevacizumab

IPC classification:
A61K 35/76, A61K 39/395, A61P 35/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP10859141

PREPARATION METHOD AND USE FOR FLUORINE-CONTAINING MICROEMULSION

IPC classification:
C08F 2/26, C08G 65/00, C08L 71/00
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11165926

Use of the active ingredient combination of a 1-diethylaminoethyl-3-chinoxalin-2-on derivative and an oxysterol for breaking resistance in the treatment of cancer and strengthening the immune system against cancer, bacterial and viral diseases, autoimmune diseases, increased stress and environmental influences

IPC classification:
A61K 31/498, A61K 31/575, A61P 37/04, A61P 39/06
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11007684

MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer

IPC classification:
A61K 39/00
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13001576

Methods to improve vector expression and genetic stability

IPC classification:
C07K 14/005, C12N 15/67, C12N 15/68
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11781740

A NEW DIMEDON DERIVATIVE AND A METHOD FOR THE PURIFICATION OF PNA AND PEPTIDE OLIGOMERS

IPC classification:
C07D 209/94, C07D 403/12, C07D 405/12, C07D 487/08, C07K 1/00, C07K 1/14, C07K 1/22, C07K 14/00, C07K 17/14
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11724363

METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF A TUMOR USING BCAT1 PROTEIN

IPC classification:
G01N 33/574
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14860926

AQUEOUS SUSPENSION PREPARATION COMPRISING NANOPARTICLES OF MACROLIDE ANTIBACTERIAL AGENT

IPC classification:
A61K 9/10, A61K 9/72, A61K 31/7048, A61K 47/10, A61K 47/26, A61K 47/32, A61K 47/34, A61K 47/38, A61P 29/00, A61P 31/04
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP15159852

LUNG CANCER THERAPY WITH A RODENT PARVOVIRUS

IPC classification:
A61K 35/768, A61P 35/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION PUBLISHED
EP12705971

INHIBITORS OF BRANCHED-CHAIN-AMINOTRANSFERASE-1 (BCAT1) FOR THE TREATMENT OF BRAIN TUMORS

IPC classification:
A61K 31/196, A61K 31/713, A61K 39/395, A61P 35/00, C12N 15/113
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16020092

SOLUBLE HIV-1 ENVELOPE GLYCOPROTEIN TRIMERS

IPC classification:
A61K 39/21, C07K 14/16
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP11007685

p16INK4a derived peptides for prophylaxis and therapy of HPV-associated tumors and other p16INK4a expressing tumors

IPC classification:
A61K 39/00, C07K 14/47, C07K 16/08
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11730197

PARVOVIRUS FOR TREATMENT OF TUMOURS BY INTRANASAL APPLICATION

IPC classification:
A61K 35/76, A61K 48/00, A61P 35/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
PATENT GRANTED
EP13159236

Vector(s) containing an inducible gene encoding a CDK4/CDK6 inhibitor useful for treating neurodegenerative disorders

IPC classification:
C07K 14/47
Applicant:
Universität Leipzig KöR
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15002246

TARGETED NANOCARRIERS FOR TARGETED DRUG DELIVERY OF GENE THERAPEUTICS

IPC classification:
A61K 9/127, A61K 38/00, A61K 47/48
Applicant:
Rodos BioTarget GmbH
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION PUBLISHED
EP15166303

COMBINATION OF A BISPECIFIC ANTIBODY WITH AN IMMUNE MODULATING MOLECULE FOR THE TREATMENT OF A TUMOR

IPC classification:
A61K 39/00, A61P 35/00, C07K 16/28
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION PUBLISHED
EP15737029

MULTIPLEXING TRANSCRIPTION FACTOR REPORTER PROTEIN ASSAY PROCESS AND SYSTEM

IPC classification:
C12Q 1/68
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION WITHDRAWN
EP11004729

Modulators of glycerol-3-phosphate dehydrogenase (GPD2) for therapy

IPC classification:
A61P 35/00, A61P 37/00, C07K 14/435, C12N 15/113
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15745856

BIO-DERIVED COMPOSITIONS FOR USE IN AGRICULTURE

IPC classification:
A01N 63/02, A01N 65/00, A01P 3/00, A01P 21/00
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP15173308

PARVOVIRUS FORMULATION FOR TREATING TUMORS

IPC classification:
A61K 9/00, A61K 35/768, A61K 47/24, A61P 35/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION PUBLISHED
EP15755646

TC-PTP INHIBITORS AS APC ACTIVATORS FOR IMMUNOTHERAPY

IPC classification:
A61K 31/67, A61K 35/15, A61P 31/00, A61P 31/18, A61P 33/00, A61P 35/00, A61P 37/02, C07F 9/6553, C12N 5/078, C12N 9/16
Applicant:
McGill University - The Royal Institution for the Advancement of Learning
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP15754442

4-BENZYLSULFONYL-2-BUTENENITRILE

IPC classification:
A61K 31/10
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP16020116

SWITCH CIRCUIT AND METHOD OF SWITCHING RADIO FREQUENCY SIGNALS

IPC classification:
H01P 1/15, H03K 17/06, H03K 17/08, H03K 17/10, H03K 17/687, H03K 17/693, H03K 19/0185, H03K 19/0944
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION PUBLISHED
EP14884887

METHOD OF PREPARATION AND CHIRAL INVERSION OF CHIRAL-1-T-BUTOXYCARBONYL-3-HYDROXY PIPERIDINE

IPC classification:
C07B 53/00, C07D 211/42
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP16020095

MEDICAL INSTRUMENT WITH X-RAY MARKER PARTICLES AND MR MARKERS

IPC classification:
A61L 27/50, A61L 29/18, A61L 31/18
Applicant:
MaRVis Interventional GmbH
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION PUBLISHED
EP15721566

METHOD FOR OBTAINING NAPIN AND CRUCIFERIN OR A MIXTURE THEREOF FROM RAPESEED

IPC classification:
A23J 1/14, A23J 3/16
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP15719420

TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE

IPC classification:
C07K 16/28, C07K 16/46
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP15735845

ROD-SHAPED BODY AND MEDICAL INSTRUMENT

IPC classification:
A61L 31/18
Applicant:
MaRVis Interventional GmbH
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP16787706

METHOD FOR REDUCING PRIMER-DIMER AMPLIFICATION

IPC classification:
C07H 21/04, C12P 19/34, C12Q 1/68
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP16002117

REPLICATION-COMPETENT VSV-HIV ENV VACCINES

IPC classification:
A61K 39/21, C12N 7/00
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION PUBLISHED
EP15189665

MULTIVALENT FV ANTIBODIES

IPC classification:
C07K 16/28
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION PUBLISHED
EP16817388

SYSTEM AND METHOD FOR OPTIMIZING AND ENHANCING VISIBILITY OF THE WEBSITE

IPC classification:
G06F 7/00, G06F 15/00, G06F 17/30
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP15891984

A NEW INSTANT MESSAGING(IM) ROUTING METHOD AND ROUTER

IPC classification:
G06F 13/00, H04L 12/70, H04L 12/721
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP15818554

VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS

IPC classification:
A61M 31/00
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP15756850

CD3 BINDING DOMAIN

IPC classification:
C07K 16/28, C07K 16/30, C07K 16/46
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
EXAMINATION REQUESTED
EP17151182

CATHETER DEVICE

IPC classification:
A61M 1/10, A61M 1/12
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
APPLICATION PUBLISHED
EP17150991

PHARMACEUTICAL COMPOSITION COMPRISING 7BETA- HYDROXYCHOLESTEROL SUITABLE FOR INTRAVENOUS ADMINISTRATION

IPC classification:
A61K 31/575, A61K 47/10, A61K 47/44
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
The application has been published
EP16000071

PHARMACEUTICAL COMPOSITION COMPRISING 7SS-HYDROXYCHOLESTEROL SUITABLE FOR INTRAVENOUS ADMINISTRATION

IPC classification:
A61K 31/575, A61K 47/10, A61K 47/44
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
The application has been published
EP15783953

18F-TAGGED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER

IPC classification:
A61K 51/06
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
Request for examination was made
EP17162607

CATHETER DEVICE

IPC classification:
A61M 1/10, A61M 1/12
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
The application has been published
EP16020193

CANCER THERAPY WITH AN ONCOLYTIC VIRUS COMBINED WITH A CHECKPOINT INHIBITOR

IPC classification:
A61K 35/768, A61K 39/00, A61K 39/395
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Andrea Schüssler, Huber & Schüssler
Status:
The application has been published

Please Sign in to use this feature